Roxane Paulin

6.1k total citations · 1 hit paper
73 papers, 4.4k citations indexed

About

Roxane Paulin is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Roxane Paulin has authored 73 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Pulmonary and Respiratory Medicine, 37 papers in Molecular Biology and 18 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Roxane Paulin's work include Pulmonary Hypertension Research and Treatments (47 papers), Circular RNAs in diseases (10 papers) and MicroRNA in disease regulation (8 papers). Roxane Paulin is often cited by papers focused on Pulmonary Hypertension Research and Treatments (47 papers), Circular RNAs in diseases (10 papers) and MicroRNA in disease regulation (8 papers). Roxane Paulin collaborates with scholars based in Canada, United States and France. Roxane Paulin's co-authors include Sébastien Bonnet, Evangelos D. Michelakis, Steeve Provencher, Jolyane Meloche, Gopinath Sutendra, Peter Dromparis, Alois Haromy, Audrey Courboulin, Olivier Boucherat and Trevor H. Stenson and has published in prestigious journals such as Cell, Nucleic Acids Research and Circulation.

In The Last Decade

Roxane Paulin

71 papers receiving 4.4k citations

Hit Papers

A Nuclear Pyruvate Dehydrogenase Complex Is Important for... 2014 2026 2018 2022 2014 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roxane Paulin Canada 34 2.6k 2.3k 1.1k 1.1k 410 73 4.4k
Gopinath Sutendra Canada 26 1.4k 0.6× 2.2k 1.0× 1.2k 1.0× 820 0.8× 343 0.8× 49 3.8k
Stewart Fleming United Kingdom 35 2.1k 0.8× 4.2k 1.9× 1.2k 1.1× 520 0.5× 817 2.0× 83 6.3k
Peter Dromparis Canada 16 828 0.3× 1.6k 0.7× 862 0.8× 416 0.4× 299 0.7× 25 2.7k
Joshua M. Spin United States 32 981 0.4× 1.2k 0.6× 831 0.7× 594 0.5× 773 1.9× 74 3.2k
Linda A. Gleaves United States 35 1.2k 0.5× 1.1k 0.5× 477 0.4× 582 0.5× 869 2.1× 52 3.5k
Takeo Kosaka Japan 39 1.6k 0.6× 1.7k 0.8× 838 0.7× 371 0.3× 1.5k 3.6× 290 4.8k
Weiyi Fang China 37 470 0.2× 2.9k 1.3× 1.8k 1.5× 398 0.4× 601 1.5× 138 4.5k
Kristof Graf Germany 33 379 0.1× 1.4k 0.6× 558 0.5× 899 0.8× 602 1.5× 81 3.5k
Delphine Gomez United States 22 570 0.2× 1.8k 0.8× 617 0.5× 432 0.4× 476 1.2× 35 3.3k
Robert L. Wolfert United States 34 1.4k 0.5× 1.7k 0.7× 706 0.6× 152 0.1× 806 2.0× 55 4.6k

Countries citing papers authored by Roxane Paulin

Since Specialization
Citations

This map shows the geographic impact of Roxane Paulin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roxane Paulin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roxane Paulin more than expected).

Fields of papers citing papers by Roxane Paulin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roxane Paulin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roxane Paulin. The network helps show where Roxane Paulin may publish in the future.

Co-authorship network of co-authors of Roxane Paulin

This figure shows the co-authorship network connecting the top 25 collaborators of Roxane Paulin. A scholar is included among the top collaborators of Roxane Paulin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roxane Paulin. Roxane Paulin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bradley, Jenna, Patrick OʼShea, Johan Mattsson, et al.. (2025). A secretome screen in primary human lung fibroblasts identifies FGF9 as a novel regulator of cellular senescence. SLAS DISCOVERY. 32. 100223–100223. 1 indexed citations
2.
Shimauchi, Tsukasa, Olivier Boucherat, Tetsuro Yokokawa, et al.. (2022). PARP1-PKM2 Axis Mediates Right Ventricular Failure Associated With Pulmonary Arterial Hypertension. JACC Basic to Translational Science. 7(4). 384–403. 26 indexed citations
3.
Wu, Wenhui, Karima Habbout, Sandra Breuils‐Bonnet, et al.. (2021). R-Crizotinib predisposes to and exacerbates pulmonary arterial hypertension in animal models. European Respiratory Journal. 57(5). 2003271–2003271. 7 indexed citations
4.
Malenfant, Simon, Marius Lebret, François Potus, et al.. (2021). Exercise intolerance in pulmonary arterial hypertension: insight into central and peripheral pathophysiological mechanisms. European Respiratory Review. 30(160). 200284–200284. 31 indexed citations
5.
Wu, Wenhui, Sébastien Bonnet, Tsukasa Shimauchi, et al.. (2021). Potential for inhibition of checkpoint kinases 1/2 in pulmonary fibrosis and secondary pulmonary hypertension. Thorax. 77(3). 247–258. 16 indexed citations
6.
Vitry, Géraldine, Roxane Paulin, Marie-Claude Lampron, et al.. (2020). Oxidized DNA Precursors Cleanup by NUDT1 Contributes to Vascular Remodeling in Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 203(5). 614–627. 25 indexed citations
7.
Paulin, Roxane, Marie-Claude Lampron, Géraldine Vitry, et al.. (2020). Therapeutic Potential of the Nuclear Receptor Modulator SR9011 for Treatment of Pulmonary Hypertension. A7672–A7672. 2 indexed citations
8.
Feen, Diederik E. van der, Kondababu Kurakula, Ève Tremblay, et al.. (2019). Multicenter Preclinical Validation of BET Inhibition for the Treatment of Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 200(7). 910–920. 96 indexed citations
9.
Shimauchi, Tsukasa, Junichi Omura, Sandra Breuils Bonnet, et al.. (2019). Abstract 12208: Role Of PKM2 and Oxidative DNA Damage in the Pathogenesis of Right Ventricular Failure Associated With Pulmonary Arterial Hypertension. Circulation. 2 indexed citations
10.
Boucherat, Olivier, Alice Bourgeois, Valérie Nadeau, et al.. (2018). Mitochondrial HSP90 Accumulation Promotes Vascular Remodeling in Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 198(1). 90–103. 79 indexed citations
11.
Brittain, Evan L., Bradley A. Maron, Stephen Y. Chan, et al.. (2018). Update in Pulmonary Vascular Disease 2016 and 2017. American Journal of Respiratory and Critical Care Medicine. 198(1). 13–23. 5 indexed citations
12.
Boucherat, Olivier, Sébastien Bonnet, & Roxane Paulin. (2016). The HIPPO-Thesis of Pulmonary HYPERtension. American Journal of Respiratory and Critical Care Medicine. 194(7). 787–789. 4 indexed citations
13.
Kinnaird, Adam, Peter Dromparis, Bruno Saleme, et al.. (2016). Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase. European Urology. 69(4). 734–744. 62 indexed citations
14.
Potus, François, Grégoire Ruffenach, Abdellaziz Dahou, et al.. (2015). Downregulation of MicroRNA-126 Contributes to the Failing Right Ventricle in Pulmonary Arterial Hypertension. Circulation. 132(10). 932–943. 168 indexed citations
15.
Meloche, Jolyane, Roxane Paulin, Steeve Provencher, & Sébastien Bonnet. (2015). Therapeutic Potential of microRNA Modulation in Pulmonary Arterial Hypertension. Current Vascular Pharmacology. 13(3). 331–340. 25 indexed citations
16.
Paulin, Roxane, Peter Dromparis, Gopinath Sutendra, et al.. (2014). Sirtuin 3 Deficiency Is Associated with Inhibited Mitochondrial Function and Pulmonary Arterial Hypertension in Rodents and Humans. Cell Metabolism. 20(5). 827–839. 163 indexed citations
17.
Meloche, Jolyane, Aude Pflieger, Mylène Vaillancourt, et al.. (2013). Role for DNA Damage Signaling in Pulmonary Arterial Hypertension. Circulation. 129(7). 786–797. 198 indexed citations
18.
Renard, Sébastien, Roxane Paulin, Sandra Breuils‐Bonnet, et al.. (2013). Pim‐1: A New Biomarker in Pulmonary Arterial Hypertension. Pulmonary Circulation. 3(1). 74–81. 37 indexed citations
19.
Sutendra, Gopinath, Peter Dromparis, Roxane Paulin, et al.. (2013). A metabolic remodeling in right ventricular hypertrophy is associated with decreased angiogenesis and a transition from a compensated to a decompensated state in pulmonary hypertension. Journal of Molecular Medicine. 91(11). 1315–1327. 168 indexed citations
20.
Courboulin, Audrey, Véronique Tremblay, Marjorie Barrier, et al.. (2011). Krüppel-like Factor 5 contributes to pulmonary artery smooth muscle proliferation and resistance to apoptosis in human pulmonary arterial hypertension. Respiratory Research. 12(1). 128–128. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026